Tafnat Tablet

# Tafnat Tablet: Tenofovir Alafenamide 25mg

Tenofovir alafenamide works by blocking the reverse transcriptase enzyme that the human immunodeficiency virus depends on to replicate. Once absorbed, the body converts it into its working form inside infected cells. This targeted cellular activity means higher concentrations reach the site of action with a lower circulating dose compared to older compounds in the same drug category. The mechanism is well understood.

Tafnat Tablet 25mg is the product built around this compound. It contains tenofovir alafenamide as the active ingredient at a strength of 25mg per tablet. The manufacturer for this product is [MANUFACTURER]. Buyers looking for a tenofovir alafenamide generic manufacturer with a consistent supply record will find Tafnat Tablet 25mg a straightforward stocking option.

What This Product Treats

Tafnat Tablet is used for the treatment of human immunodeficiency virus type 1 infection in adults. It belongs to the nucleotide reverse transcriptase inhibitor drug class. A category known for strong viral suppression activity. The product is typically combined with other antiretroviral agents as part of a complete treatment regimen. Demand for this drug class remains ongoing across all major markets.

Available Strengths and Pack Sizes

The available strength for Tafnat Tablet is 25mg. Pack size details beyond the 25mg tablet configuration are not confirmed in current product listings. Buyers placing a Tafnat Tablet bulk order should contact Get HIV Treatment directly to confirm current pack formats and minimum order quantities. Strip-level pricing is available on request for resellers evaluating cost per unit.

Side Effect

The side effect of Tafnat Tablet 25mg is typical of this drug class. Commonly reported effects include nausea, headache, and fatigue, particularly in the early period of use. Renal and bone effects, which were a more prominent concern with the older tenofovir disoproxil fumarate formulation, are reported at lower rates with tenofovir alafenamide at this strength. This profile makes it a preferred stocking choice for buyers supplying long-term treatment programs. The overall tolerability data is favorable.

Shelf Life and Storage

Tafnat Tablet 25mg should be stored below 30 degrees Celsius in dry conditions away from direct moisture and light. Standard blister packaging protects tablet integrity during transit and warehousing. Buyers stocking this product for redistribution should store it in a temperature-controlled environment consistent with standard pharmaceutical storage requirements. Shelf life is typical of solid oral antiretroviral tablets in this category.

Pricing and Availability

Get HIV Treatment carries Tafnat Tablet 25mg for resellers and stockists. Pricing per strip and per unit is available through the product listing, with wholesale rates applying to volume orders. Buyers placing a Tafnat Tablet wholesale inquiry can request bulk order pricing directly through the platform. This product is available where antiretroviral medications are permitted for online ordering and resale under applicable regulations.

Why Buyers Stock Tafnat Tablet

The market for tenofovir alafenamide-based products is stable and growing. Treatment guidelines in multiple regions have shifted toward this compound over older tenofovir formulations, which means resellers are seeing consistent reorder volume from both institutional and retail channels. The Tafnat Tablet reseller opportunity is straightforward. A well-recognised active ingredient, a clear treatment category, and ongoing demand. Buyers buying Tafnat Tablet in bulk benefit from a product with predictable sell-through. The 25mg strength is the established standard for this compound, which simplifies inventory planning across pack formats.

Stocking tenofovir alafenamide in a reliable generic form positions a reseller well within the antiretroviral supply chain. The compound’s reputation for a cleaner side effect profile compared to earlier-generation alternatives has made it the preferred option in updated treatment protocols. That preference drives consistent demand at the wholesale level.